Showing results (131-140 of 198) with videos related to

Sort By:
Pageof 20
American Heart Journal|June 23, 2026
DOAC Score Among Patients Receiving Vitamin K AntagonistsRahul Aggarwal, Christian T Ruff, Michael G Palazzolo, et al.
European Heart Journal|April 30, 2026
Direct oral anticoagulants vs warfarin in Asian vs non-Asian patients with atrial fibrillation: a patient-level meta-analysis from COMBINE AFTze-Fan Chao, Eugene Braunwald, Michael G Palazzolo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 3, 2015
Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesionsNagendra R Pokala, Rohan V Menon, Siddharth M Patel, et al.
Nature Medicine|February 26, 2025
Endothelial cell-related genetic variants identify LDL cholesterol-sensitive individuals who derive greater benefit from aggressive lipid loweringNicholas A Marston, Frederick K Kamanu, Giorgio E M Melloni, et al.
Circulation|April 1, 2020
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous ThromboembolismNicholas A Marston, Yared Gurmu, Giorgio E M Melloni, et al.
Journal of Thrombosis and Haemostasis : JTH|February 5, 2026
Evaluation of the updated ABC-AF-bleeding score 2.0 in patients with atrial fibrillation treated with a direct oral anticoagulant or warfarinZiad Hijazi, Johan Lindbäck, Jonas Oldgren, et al.
JAMA|November 18, 2011
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular diseaseJessica L Mega, Willibald Hochholzer, Andrew L Frelinger, et al.
The Lancet. Diabetes & Endocrinology|November 28, 2024
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trialsSunil V Badve, Anika Bilal, Matthew M Y Lee, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2021
LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery DiseaseChristian T Ruff, Michael J Koren, Joseph Grimsby, et al.
JAMA Cardiology|December 28, 2022
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary PreventionNicholas A Marston, James P Pirruccello, Giorgio E M Melloni, et al.
Pageof 20